Results 151 to 160 of about 3,045,873 (317)

Editorial: Real-world data and real-world evidence in hematologic malignancies

Frontiers in Oncology, 2023
Malagola, Michele, Ohgami, Robert, Greco, Raffaella   +2 more
openaire   +4 more sources

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

Somatic mutational landscape in von Hippel–Lindau familial hemangioblastoma

Molecular Oncology, EarlyView.
The causes of central nervous system (CNS) hemangioblastoma in Von Hippel–Lindau (vHL) disease are unclear. We used Whole Exome Sequencing (WES) on familial hemangioblastoma to investigate events that underlie tumor development. Our findings suggest that VHL loss creates a permissive environment for tumor formation, while additional alterations ...
Maja Dembic, Anne Nørremølle, Lilian Bomme Ousager, Lars van Brakel Andersen, Marie Louise Mølgaard Binderup, Mads Thomassen   +5 more
wiley   +1 more source

A Typology of Approaches for Real-time Monitoring

In recent years, the World Bank’s Poverty and Equity Global Practice (GP) has increased its capacity to provide more timely information on welfare.
World Bank
core   +1 more source

Advancing real-world evidence harmonization: lessons from the UK, EMA and global policy frameworks

Journal of Comparative Effectiveness Research
Aim: Real-world evidence (RWE) – defined here as clinical evidence derived from the analysis of realworld data (RWD) on patient health status and healthcare delivery – has become a cornerstone of regulatory and health technology assessment (HTA ...
Alexandros Sagkriotis
doaj   +1 more source

When can real‐world data generate real‐world evidence?

Pharmacoepidemiology and Drug Safety, 2023
Motiur Rahman, Gerald Dal Pan, Peter Stein, Mark Levenson, Stefanie Kraus, Aloka Chakravarty, Donna R. Rivera, Richard Forshee, John Concato   +8 more
openaire   +2 more sources

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Real-World or Controlled Clinical Trial Data in Real-World Practice [PDF]

Journal of Thoracic Oncology, 2018
Ting-Hui, Wu, James Chih-Hsin, Yang
openaire   +2 more sources

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Hospital readmissions following catheter ablation for atrial fibrillation with THERMOCOOL™ STSF/ THERMOCOOL™ ST catheter with CARTO™ 3 system versus TactiCath™ catheter with EnSite™ system

Journal of Comparative Effectiveness Research
Aim: Radiofrequency (RF) catheter ablation (CA) is a mainstay treatment for atrial fibrillation (AF). RF catheters with contact force (CF) sensing technology and electroanatomical mapping systems enable real-time assessment of catheter tip-tissue ...
Alexandru I Costea, Rahul Khanna, Maximiliano Iglesias, Yiran Rong   +3 more
doaj   +1 more source